Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Filter
  • 1-3 ل  3 نتائج ل ""Protein Kinase Inhibitors / pharmacology""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Fadraciclib (CYC065), a novel CDK inhibitor, targets key pro-survival and oncogenic pathways in cancer

Subjects: Adenosine/analogs & derivatives; Animals; Antineoplastic Agents/pharmacology

  • Source: Frame , S , Saladino , C , MacKay , C , Atrash , B , Sheldrake , P , McDonald , E , Clarke , P A , Workman , P , Blake , D & Zheleva , D 2020 , ' Fadraciclib (CYC065), a novel CDK inhibitor, targets

تفاصيل العنوان

×
Academic Journal

Preclinical Evaluation of AZ12601011 and AZ12799734, Inhibitors of Transforming Growth Factor β Superfamily Type 1 Receptors.

Subjects: Activin Receptors; Type I/metabolism; Animals

  • Source: Spender , L C , Ferguson , G J , Hughes , G D , Davies , B R , Goldberg , F W , Herrera , B , Taylor , R G , Strathearn , L , Sansom , O J , Barry , S T & Inman , G 2019 , ' Preclinical Evaluation of

تفاصيل العنوان

×
Academic Journal

Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils

Subjects: Animals; Antibodies; Monoclonal/chemistry

  • Source: Fan , Y , Howden , A J M , Sarhan , A R , Lis , P , Ito , G , Martinez , T N , Brockmann , K , Gasser , T , Alessi , D R & Sammler , E 2018 , ' Interrogating Parkinson's disease LRRK2

تفاصيل العنوان

×
  • 1-3 ل  3 نتائج ل ""Protein Kinase Inhibitors / pharmacology""